UPA Ciagra 120mg

UPA Ciagra 120mg is a dual-compound oral formulation listed as containing Sildenafil Citrate (100mg) and Tadalafil (20mg) per tablet. Each pack contains 10 tablets, with a combined stated strength of 120mg per tablet.

Both active compounds belong to a class of medications known as Phosphodiesterase Type 5 (PDE5) inhibitors, which are used in the treatment of erectile dysfunction (ED).

Ciagra combines two PDE5 inhibitors with different durations of action. Sildenafil generally has a shorter duration of activity, while tadalafil can remain active for up to 36 hours. However, combining these medications increases the risk of adverse effects and is not an established standard treatment for erectile dysfunction.

What UPA Ciagra Is Used For

Sildenafil and tadalafil are individually used to treat erectile dysfunction by improving blood flow to penile tissue during sexual stimulation.

Their recognised effects and medical applications include:

• Erectile Dysfunction Support: Both compounds are individually approved for treating erectile dysfunction in adult men.
• Improved Penile Blood Flow: Help relax blood vessels in erectile tissue, allowing increased blood flow during sexual stimulation.
• Erectile Function: May improve the ability to achieve and maintain an erection in men experiencing erectile dysfunction.
• Vascular Relaxation: Influence nitric oxide-related signalling pathways involved in blood vessel relaxation.
• Duration of Activity: Tadalafil has a longer duration of action than sildenafil, although combining them does not establish greater effectiveness or safety.
• Sexual Performance: Treatment of erectile dysfunction may improve sexual function when difficulties are caused by inadequate erectile response.

Important: Sildenafil and tadalafil do not directly increase sexual desire. Sexual stimulation is still required for their erectile effects.

The combined formulation should not be assumed to provide greater benefits than either medication individually.

How UPA Ciagra Works

UPA Ciagra contains two compounds that work through the same primary biological pathway: Phosphodiesterase Type 5 (PDE5) inhibition.

During sexual stimulation, nitric oxide is released in penile tissue, increasing cyclic guanosine monophosphate (cGMP). This chemical messenger promotes smooth muscle relaxation and increased blood flow.

Sildenafil and tadalafil inhibit the PDE5 enzyme, which normally breaks down cGMP.

Their primary mechanisms include:

• PDE5 Inhibition: Both compounds inhibit the enzyme responsible for breaking down cGMP.
• Nitric Oxide Signalling: Enhance the effects of naturally released nitric oxide during sexual stimulation.
• Smooth Muscle Relaxation: Promote relaxation of smooth muscle within penile blood vessels.
• Increased Blood Flow: Support increased blood circulation to erectile tissue.
• Sildenafil Activity: Sildenafil typically produces effects lasting approximately 4–5 hours.
• Tadalafil Activity: Tadalafil has a longer duration of action, potentially lasting up to 36 hours.
• Combined PDE5 Activity: Both compounds act on the same pathway, potentially increasing the intensity of blood-pressure-related effects and adverse reactions.

Possible Side Effects

Sildenafil and tadalafil may cause adverse effects associated with blood vessel relaxation and changes in blood pressure. Combining the two compounds can increase the likelihood or severity of these reactions.

Common or Recognised Side Effects:

• Headaches.
• Facial flushing or redness.
• Nasal congestion.
• Dizziness or light-headedness.
• Indigestion or gastrointestinal discomfort.
• Nausea.
• Back pain or muscle aches.
• Temporary visual disturbances.
• Blurred vision or changes in colour perception.
• Heart palpitations.
• Reduced blood pressure.